Embecta (NASDAQ:EMBC) & Tenon Medical (NASDAQ:TNON) Head-To-Head Survey

Embecta (NASDAQ:EMBCGet Free Report) and Tenon Medical (NASDAQ:TNONGet Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

Volatility & Risk

Embecta has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, Tenon Medical has a beta of 2.32, indicating that its stock price is 132% more volatile than the S&P 500.

Insider and Institutional Ownership

93.8% of Embecta shares are owned by institutional investors. Comparatively, 21.7% of Tenon Medical shares are owned by institutional investors. 0.3% of Embecta shares are owned by insiders. Comparatively, 8.4% of Tenon Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Embecta and Tenon Medical, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Embecta 1 1 0 0 1.50
Tenon Medical 0 0 1 0 3.00

Embecta presently has a consensus target price of $16.00, indicating a potential downside of 6.38%. Tenon Medical has a consensus target price of $6.00, indicating a potential upside of 383.87%. Given Tenon Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Tenon Medical is more favorable than Embecta.

Profitability

This table compares Embecta and Tenon Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Embecta 6.28% -20.56% 13.88%
Tenon Medical -849.06% -670.24% -226.82%

Earnings and Valuation

This table compares Embecta and Tenon Medical’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Embecta $1.12 billion 0.88 $70.40 million $1.21 14.12
Tenon Medical $690,000.00 4.44 -$18.92 million ($16.06) -0.08

Embecta has higher revenue and earnings than Tenon Medical. Tenon Medical is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks.

Summary

Embecta beats Tenon Medical on 8 of the 14 factors compared between the two stocks.

About Embecta

(Get Free Report)

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

About Tenon Medical

(Get Free Report)

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as stabilizes and transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

Receive News & Ratings for Embecta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Embecta and related companies with MarketBeat.com's FREE daily email newsletter.